DNA analysis at p53 locus in adenoid cystic carcinoma: Comparison of molecular study and p53 immunostaining

Pathology International

Volumn 48, Issue 4, 1998, Pages 273-280

  Yamamoto, Yuzo ^a,b   Wistuba, Ignacio I ^a   Kishimoto, Yosuke ^a   Virmani, Arvind K ^a   Vuitch, Frank ^a   Albores Saavedra, Jorge ^a   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Adenoid cystic carcinoma; Immunohistochemistry; Loss of heterozygosity; P53 gene; Salivary gland carcinoma

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA DETERMINATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA;

EID: 0031820568     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03905.x     Document Type: Article

References (36)

1. Ellis GL, Auclair PL. Tumors of the Salivary Glands. Atlas of Tumor Pathology, Fascicle 17, Series 3. Armed Forces Institute of Pathology, Washington DC, 1995; 203-216.
2. Chaudhry AP, Vickers RA, Gorlin RJ: Intraoral minor salivary gland tumors. Oral Surg. Oral Med. Oral Pathol. 1961; 14: 1194-1226.
3. Eneroth C-M. Salivary gland tumors in the parotid gland, submandibular gland and the palate region. Cancer 1971; 27: 1415-1418.
4. Tomich CE. Adenoid cystic carcinoma. In: GL Ellis, PL Auclair, DR Gnepp, eds. Surgical Pathology of the Salivary Glands. WB Saunders, Philadelphia, 1991; 333-349.
5. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinoma arising in salivary glands; a correlation of histologic features and clinical course. Cancer 1978; 42: 265-282.
6. Billroth T. Beobachtung über Geschwulste der Speicheldrüsen. Virchows Arch. Pathol Anat. Histopathol. 1859; 17: 357-375.
7. Evans RW, Cruickshank AH. Epithelial Tumors of the Salivary Glands. WB Saunders, Philadelphia, 1970.
8. Eby LS, Johnson DS, Baker HW. Adenoid cystic carcinoma of the head and neck. Cancer1972; 29: 1160-1168.
9. Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ. Adenoid cystic salivary gland carcinoma: A histopathologic review of treatment failure patterns. Cancer 1986; 57: 519-524.
10. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984; 54: 1062-1069.
11. Saka T, Yamamoto Y, Takahashi H. Comparative cytofluorometric DNA analysis of pleomorphic adenoma and adenoid cystic carcinoma of the salivary glands. Virchows Arch. B Cell Pathol. 1991; 61: 255-261.
12. Franzén G, Nordgård S, Boysen M, Larsen PL, Halvorsen TB, Clausen OPF. DNA content in adenoid cystic carcinomas. Head Neck 1995; 17: 49-55.
13. Yamamoto Y, Itoh T, Saka T, Takahashi H. Nucleolar organizer regions in adenoid cystic carcinoma of the salivary glands. Eur. Arch. Otorhinolaryngol. 1995; 252: 176-180.
14. Stenman G, Sandros J, Dahlenfors R, Juberg-Ode M, Mark J. 6q- and loss of the Y chromosome: Two common deviations in malignant human salivary gland tumors. Cancer Genet. Cytogenet. 1986; 22: 283-293.
15. Higashi K, Jin Y, Johansson M et al. Rearrangement of 9p13 as the primary chromosomal aberration in adenoid cystic carcinoma of the respiratory tract. Genes Chromosomes Cancer 1991; 3: 21-23.
16. Nordkvist A, Joachim M, Gustafsson H, Bang G, Stenman G. Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer 1994; 10: 115-121.
17. Yamamoto Y, Virmani AK, Wistuba II et al. Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands. Hum. Pathol. 1996; 27: 1204-1210.
18. Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705-708.
19. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
20. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54: 4855-4878.
21. Soini Y, Kamel D, Nuorva K, Lane DP, Vahakangas K, Paakko P. Low p53 protein expression in salivary gland tumors compared with lung carcinomas. Virchows Arch. A Pathol. Anat. Histopathol. 1992; 421: 415-420.
22. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 1995; 75: 2037-2044.
23. Whetsell L, Maw G, Nadon N, Ringer DP, Schaefer FV. Polymerase chain reaction microanalysis of tumors from stained histological slides. Oncogens 1992; 7: 2355-2361.
24. Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat. Genes Chromosomes Cancer 1992; 5: 89-90.
25. Futreal PA, Barrett JC, Wiseman RW. An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res. 1991; 19: 6977.
26. Kishimoto Y, Sugio K, Mitsudomi T et al. Frequent loss of the short arm of the chromosome 9 in resected non-small cell lung cancer from Japanese patients and its association with squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 1995; 121: 291-296.
27. Hung J, Kishimoto Y, Sugio K et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995; 273: 558-563.
28. Battifora H. p53 immunohistochemistry: A word of caution (editorial). Hum. Pathol. 1994; 25: 435-437.
29. Wistuba II, Sugio K, Hung J et al. Allele specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995; 55: 2511-2515.
30. Yamamoto Y, Kishimoto Y, Virmani AK et al. Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum. Pathol. 1996; 27: 782-786.
31. Knudson AG. Hereditary cancers: Clues to mechanisms of carcinogenesis. Br. J. Cancer 1989; 59: 661-666.
32. Levine AJ, Momand L, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
33. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992; 70: 923-935.
34. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992; 70: 937-948.
35. Milner J, Cook A, Mason J. p53 is associated with p34cdc-2 in transformed cells. EMBO J. 1990; 9: 2885-2889.
36. Morinaga S, Nakajima T Shimosato Y, Saitoh H, Ebihara S, Ono I. Histologic factors influencing prognosis of adenoid cystic carcinoma of the head and neck. Jpn. J. Clin. Oncol. 1986; 16: 29-40.